This Wednesday morning, fans of luxury fashion brand Christian Dior and the rest of the world have been notified of Creative Director Raf Simons’ departure. The designer, according to his statement, cites personal reasons as to why he is leaving the French fashion house.
“It is a decision based entirely and equally on my desire to focus on other interests in my life, including my own brand, and the passions that drive me outside my work. Christian Dior is an extraordinary company, and it has been an immense privilege to write a few pages of this magnificent book,” part of Simon’s statement read.
Simons, who has also worked at fashion house Jil Sander, was known for his minimalist designs, Papermag said.
WWD, which cited industry sources, have said Simon’s successor has yet to be identified, and the company is on a manhunt to fill the gap left by the famous designer. The sources also disclosed that Simons’ departure was also due to the disagreement over his new employment contract.


Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 



